Dow Jones

40,413.87

0.31%

Customisable watchlists with full streaming quotes from leading exchanges, such as LSE, NASDAQ, NYSE, AMEX, Bovespa, BIT and more.

Get Started

Home
Investing
Stocks
UK
LSE
Celadon Pharmaceuticals Plc (CEL)
Celadon Pharmaceuticals Plc (CEL) News

CEL Celadon Pharmaceuticals Plc

61.00

1.50 (2.52%)

22 Jul 2024 - Closed

Delayed by 15 minutes

Share Name	Share Symbol	Market	Type	Share ISIN	Share Description
Celadon Pharmaceuticals Plc	LSE:CEL	London	Ordinary Share	GB00BDQYGP38	ORD 1P

	Price Change	% Change	Share Price	Bid Price	Offer Price	High Price	Low Price	Open Price	Shares Traded	Last Trade
	1.50	2.52%	61.00	57.00	65.00	61.00	59.50	59.50	12,246	14:00:11

Industry Sector	Turnover	Profit	EPS - Basic	PE Ratio	Market Cap
Investment Advice	149k	-7.14M	-0.1082	-5.64	39.26M

Director/PDMR Shareholding

31/07/2007 4:30pm

UK Regulatory

RNS Number:2333B
Celsis International PLC
31 July 2007



                            Celsis International plc

                                 Share Options

31 July 2007: Celsis International plc today announces that according to the
2005 Share Performance Plan, Jay LeCoque, Chief Executive and Christian
Madrolle, Finance Director, have respectively been awarded 99,305 and 84,269
Share Options at a price of 5p per share on 26 July 2007.

These Share Options are subject to the achievement of performance criteria as
detailed in the Share Performance Plan.



Enquiries:


Celsis International plc                                     Tel: 01223 598 428
Christian Madrolle, Finance Director & Company Secretary
Jenny Parsons, Corporate Communications


Financial Dynamics                                           Tel: 020 7831 3113
David Yates
Ben Atwell


                      This information is provided by RNS
            The company news service from the London Stock Exchange
END

RDSBUGDRIDXGGRB